FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to psychiatry and gynaecology. That is ensured by prescribing Valdoxane 25 mg/day for 6 months with underlying basic conservative drug-induced therapy including an insulin sensitiser.
EFFECT: method provides improved life quality and clinical effectiveness in polycystic ovary syndrome in females suffering affective and vegetative disorders due to reduction of anxiety and depression symptoms, improved functional state of the vegetative nervous system, reduced rates of disease progression, positive effect on an endocrine profile, and thereby normalised menstrual cycle with decreased indications for further application of the drug-induced hormone therapy.
1 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ENDOMETRIOSIS IN WOMEN WITH ANXIETY-AND-DEPRESSIVE DISORDERS | 2009 |
|
RU2418588C1 |
| METHOD FOR TREATING PATIENTS WITH EXOGENIC-ORGANIC BRAIN LESION | 2001 |
|
RU2194489C1 |
| METHOD FOR ALLEVIATING COMPLICATED ABSTINENCE SYNDROME | 1992 |
|
RU2067442C1 |
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
| METHOD OF CORRECTING PSYCHOEMOTIONAL DISORDERS IN CASE OF FUNCTIONAL HYPERPROLACTINEMIA WITH APPLICATION OF RADON AND INTERFERENCE THERAPY | 2009 |
|
RU2415663C1 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO FEMALE PATIENTS WITH OLIGOMENORRHEA AND OBESITY | 2014 |
|
RU2555347C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
| METHOD FOR REVEALING CLINICAL SPECIFIC OF BOUNDARY NEUROPSYCHIC DISORDERS | 2000 |
|
RU2168312C1 |
| METHOD FOR PREDICTING CLINICAL BEHAVIOR OF CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2228534C2 |
| METHOD FOR PREDICTING TREATMENT EFFECTIVENESS IN PATIENTS SUFFERING FROM DEPRESSIVE DISORDERS CAUSED BY SELECTIVE SEROTONINERGIC ANTIDEPRESSANTS | 2000 |
|
RU2177253C1 |
